Efficacy and saftey of fractional Er:YAG versus microneedling in treatment of facial rhytides

Not Applicable

• Conditions: Facial skin wrinkles.

• Registration Number: IRCT20160820029436N3
• Lead Sponsor: Deputy of Research, Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 March 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

Age 45 to 75
Mild to moderate wrinkling on the face

Exclusion Criteria

Pregnant or breast feed
History of cuagulopathy disorder or drug
Facial active Infection
Inability to fallow up visit
connective tissue disorder
History of skin cancer on face
Unrealistic expectation
Cosmetic procedures performed on the face in the last 6 month
Fitzpatrick skin phototype >III
Sensitivity to lidocain
Use isotretinoin in the last 6 month
History of keloid
Use photosensitive drug such gold, tetracyclin

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Transepidermal water loss. Timepoint: Before each treatment session and then after three month of treatment. Method of measurement: Measurement of skin biophysical properties by MPA-9 device.;Skin hydration. Timepoint: Before each treatment session and then after three month of treatment. Method of measurement: By dermatologist and using MPA-9 device.;Patient satisfaction. Timepoint: Before each treatment session monthly and then after three month of treatment. Method of measurement: Asking the patient.;Downtime. Timepoint: Before tretment every month and then after three month of treatment. Method of measurement: By dermatologist.;Clinical assessment of improvement. Timepoint: Before treatment every month and then after three month of treatment. Method of measurement: By dermatologist by comparing the patient's pictures.;Skin resonance time. Timepoint: Before treatment every month and then after three month of treatment. Method of measurement: By dermatologist and using reviscometer.